
### [NCIT:C4345](http://purl.obolibrary.org/obo/NCIT_C4345)
**Label:** Myeloproliferative Neoplasm

**Subclasses:** [NCIT:C2862](http://purl.obolibrary.org/obo/NCIT_C2862) (Primary Myelofibrosis), [NCIT:C3179](http://purl.obolibrary.org/obo/NCIT_C3179) (Chronic Neutrophilic Leukemia), [NCIT:C7303](http://purl.obolibrary.org/obo/NCIT_C7303) (Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C27350](http://purl.obolibrary.org/obo/NCIT_C27350) (Myeloproliferative Neoplasm, Unclassifiable), [NCIT:C9129](http://purl.obolibrary.org/obo/NCIT_C9129) (Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia), [NCIT:C3336](http://purl.obolibrary.org/obo/NCIT_C3336) (Polycythemia Vera), [NCIT:C3173](http://purl.obolibrary.org/obo/NCIT_C3173) (Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C9128](http://purl.obolibrary.org/obo/NCIT_C9128) (Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia), [NCIT:C7885](http://purl.obolibrary.org/obo/NCIT_C7885) (Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C4563](http://purl.obolibrary.org/obo/NCIT_C4563) (Chronic Eosinophilic Leukemia, Not Otherwise Specified), [NCIT:C3175](http://purl.obolibrary.org/obo/NCIT_C3175) (Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C7320](http://purl.obolibrary.org/obo/NCIT_C7320) (Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C9110](http://purl.obolibrary.org/obo/NCIT_C9110) (Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C41238](http://purl.obolibrary.org/obo/NCIT_C41238) (Primary Myelofibrosis, Overt Fibrotic Stage), [NCIT:C3174](http://purl.obolibrary.org/obo/NCIT_C3174) (Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C41237](http://purl.obolibrary.org/obo/NCIT_C41237) (Primary Myelofibrosis, Prefibrotic/Early Stage), [NCIT:C41233](http://purl.obolibrary.org/obo/NCIT_C41233) (Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase), [NCIT:C41232](http://purl.obolibrary.org/obo/NCIT_C41232) (Polycythemia Vera, Polycythemic Phase), [NCIT:C9070](http://purl.obolibrary.org/obo/NCIT_C9070) (Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C3407](http://purl.obolibrary.org/obo/NCIT_C3407) (Essential Thrombocythemia), 

**Class expressions from DL-Learner:**

- Thing 52.26%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 41.61%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39681](http://purl.obolibrary.org/obo/NCIT_C39681) (Neoplastic Small to Medium-Sized T-Lymphocyte with Irregular Nucleus))) 41.61%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39680](http://purl.obolibrary.org/obo/NCIT_C39680) (Doughnut Cell))) 41.61%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39679](http://purl.obolibrary.org/obo/NCIT_C39679) (Hallmark Cell))) 41.61%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39674](http://purl.obolibrary.org/obo/NCIT_C39674) (Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype))) 41.61%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39657](http://purl.obolibrary.org/obo/NCIT_C39657) (Neoplastic T-Lymphocyte with Clear Cytoplasm))) 41.61%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39652](http://purl.obolibrary.org/obo/NCIT_C39652) (Proliferation of Follicular Dendritic Cells Present))) 41.61%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39651](http://purl.obolibrary.org/obo/NCIT_C39651) (Proliferation of High Endothelial Venules Present))) 41.61%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39646](http://purl.obolibrary.org/obo/NCIT_C39646) (Erythroderma))) 41.61%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39640](http://purl.obolibrary.org/obo/NCIT_C39640) (Mucinous Degeneration))) 41.61%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39629](http://purl.obolibrary.org/obo/NCIT_C39629) (CDKN2A Gene Inactivation))) 41.61%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39628](http://purl.obolibrary.org/obo/NCIT_C39628) (Single Cell Exocytosis))) 41.61%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39627](http://purl.obolibrary.org/obo/NCIT_C39627) (Pautrier Microabscess Present))) 41.61%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39626](http://purl.obolibrary.org/obo/NCIT_C39626) (Epidermotropic Lymphocytic Infiltrate))) 41.61%


